top of page

RNA PLATFORM

sciencelens_0008.jpg

During the pandemic, RNA technology has come to the forefront for its safety, efficacy and rapid development potential.

We have established and are scaling up the three major components required for the development and production of RNA therapeutics: 

​

  • Plasmid DNA construct design and purification

  • mRNA synthesis and purification

  • Lipid nanoparticle encapsulation​​

 

If you are interested in accessing RNA vaccines and therapeutics for your research, please get in touch with Rebecca McKenzie at rmckenzie@malaghan.org.nz

MicrosoftTeams-image (43).png

Ignite Nanoparticle Assemblr

RNA machine.png

AKTA Avant 25 FPLC System

Thanks for your message!

CONTACT US

Malaghan Institute of Medical Research
Gate 7, Victoria University
Kelburn Parade, Wellington

 

PO Box 7060
Newtown, Wellington 6242
New Zealand

bottom of page